The benefits of antiretroviral therapy in the context of pregnancy are unquestionable.
> read full description
Stopping ART used solely for prevention of mother-to-child HIV transmission does not lead to short term disease progression.
No difference in prevalence of congenital anomalies based on trimester of ARV exposure.
High postpartum antiretroviral resistance rates in ARV naive women associated with pregnancy-limited antiretroviral therapy.